Toradol and Wound secretion - a phase IV clinical study of FDA data

Summary:

Wound secretion is reported as a side effect among people who take Toradol (ketorolac tromethamine), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Neurontin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Wound secretion when taking Toradol. It is created by eHealthMe based on reports of 8,757 people who have side effects when taking Toradol from the FDA, and is updated regularly.

What is Toradol?

Toradol has active ingredients of ketorolac tromethamine. It is often used in pain. eHealthMe is studying from 9,230 Toradol users. Check the latest studies of Toradol.

What is Wound secretion?

Wound secretion is found to be associated with 570 drugs and 761 conditions by eHealthMe. Check the latest studies of Wound secretion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

8,757 people reported to have side effects when taking Toradol.
Among them, 24 people (0.27%) have Wound secretion.

Among these 24 people:

How long have people been on Toradol when they have Wound secretion? *

What is the gender of people who have Wound secretion when taking Toradol? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Wound secretion when taking Toradol? *

What are other drugs people take besides Toradol? *

What are other side effects people have besides Wound secretion? *

Swelling: 15 people, 62.50%
Emotional Distress: 15 people, 62.50%
Weight Decreased: 14 people, 58.33%
Eye Irritation: 14 people, 58.33%
Mouth Ulcers: 14 people, 58.33%
Lacrimation Increased: 14 people, 58.33%
Joint Pain: 14 people, 58.33%
Infection: 14 people, 58.33%
Impaired Healing: 14 people, 58.33%
Gingival Disorder (gum disease): 14 people, 58.33%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 14 people, 58.33%
Gout (uric acid crystals building up in the body): 13 people, 54.17%
Cuts And Puncture Wounds: 11 people, 45.83%
Wound: 2 people, 8.33%
Purulent Discharge (discharge that contains pus): 2 people, 8.33%
Procedural Pain: 2 people, 8.33%
Procedural Nausea: 2 people, 8.33%
Itching: 2 people, 8.33%
Fever: 2 people, 8.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Toradol and have Wound secretion?

- Check whether Wound secretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Toradol:

Toradol (9,230 reports)

Wound secretion treatments and more:

Wound secretion (5,127 reports)

Browse all side effects of Toradol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Wound secretion:

Wound secretion (570 drugs)

Browse all the conditions that are associated with Wound secretion:

Wound secretion (761 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine (the active ingredients of Toradol) and Toradol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.